Skip navigationEnd of navigation

ODP Seeking Nominations for 2022 Early Stage Investigator Lecture

News ODP Seeking Nominations for 2022 Early Stage Investigator Lecture

September 13, 2021

The Office of Disease Prevention (ODP) is seeking nominations for its 2022 Early-Stage Investigator Lecture. The award is made annually to early-career scientists who have made significant research contributions in disease prevention but who have not yet successfully competed for an R01 or R01-equivalent National Institutes of Health (NIH) research grant.

The award winner will be invited to give a lecture at the NIH in 2022. The winner will also have the opportunity to meet and network with NIH program directors and scientists. Due to the COVID-19 pandemic, the date and in-person status of the lecture will depend on travel and meeting guidance provided by the NIH.

Nominees should have:

  • Innovative and significant research accomplishments in applied prevention research in humans, in areas that are relevant to the ODP’s mission.
  • Evidence of highly collaborative research projects, especially those that bridge disciplines to offer new approaches and ways of thinking in disease prevention research.

Please email prevention@mail.nih.gov with any questions.

Nominations are due October 29, 2021. The winner will be notified on January 14, 2022.

For more information as well as submission instructions, see the full announcement on the ODP website.

Recent News

March 26, 2024

Cancer Prevention Clinical Trials Network Presentation at NCI Board of Scientific Advisors (BSA) Meeting

September 13, 2023

I-SCORE 2023 Meeting Recap

This project is supported by the National Cancer Institute (NCI) of the National Institutes of Health under award number U24CA242637. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.

Visit the CP-CTNet Website

Copyright © 2024, Frontier Science and Technology Research Foundation, Inc. All rights reserved.

Privacy and Terms of Use